| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 90 | 2021 | 1585 | 9.400 |
Why?
|
| Cysteine Endopeptidases | 15 | 2019 | 255 | 4.040 |
Why?
|
| Gene Products, tax | 22 | 2012 | 75 | 3.500 |
Why?
|
| I-kappa B Kinase | 31 | 2015 | 251 | 3.210 |
Why?
|
| Ubiquitination | 19 | 2021 | 579 | 3.210 |
Why?
|
| Signal Transduction | 78 | 2022 | 12151 | 3.200 |
Why?
|
| Autoimmunity | 9 | 2021 | 275 | 3.000 |
Why?
|
| Lymphocyte Activation | 18 | 2021 | 1698 | 2.970 |
Why?
|
| Human T-lymphotropic virus 1 | 20 | 2012 | 101 | 2.910 |
Why?
|
| I-kappa B Proteins | 21 | 2019 | 175 | 2.690 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2022 | 1658 | 2.250 |
Why?
|
| MAP Kinase Kinase Kinases | 9 | 2015 | 195 | 2.240 |
Why?
|
| T-Lymphocytes | 30 | 2020 | 3955 | 1.990 |
Why?
|
| Ubiquitin | 12 | 2021 | 342 | 1.890 |
Why?
|
| Nuclear Proteins | 16 | 2021 | 3385 | 1.850 |
Why?
|
| Mice, Knockout | 41 | 2022 | 5804 | 1.850 |
Why?
|
| Ubiquitin-Protein Ligases | 10 | 2021 | 867 | 1.800 |
Why?
|
| T-Lymphocytes, Regulatory | 9 | 2015 | 717 | 1.790 |
Why?
|
| TNF Receptor-Associated Factor 3 | 7 | 2013 | 22 | 1.570 |
Why?
|
| CARD Signaling Adaptor Proteins | 5 | 2021 | 112 | 1.480 |
Why?
|
| Inflammation | 13 | 2022 | 2572 | 1.480 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2020 | 1059 | 1.470 |
Why?
|
| NF-kappa B p52 Subunit | 10 | 2014 | 26 | 1.450 |
Why?
|
| Cell Differentiation | 16 | 2020 | 4168 | 1.420 |
Why?
|
| Dendritic Cells | 10 | 2022 | 1119 | 1.420 |
Why?
|
| Gene Expression Regulation | 28 | 2022 | 4071 | 1.390 |
Why?
|
| Immunity, Innate | 11 | 2020 | 702 | 1.350 |
Why?
|
| Animals | 104 | 2022 | 61014 | 1.300 |
Why?
|
| Mice | 69 | 2022 | 35331 | 1.290 |
Why?
|
| Mice, Inbred C57BL | 28 | 2021 | 7173 | 1.280 |
Why?
|
| Th17 Cells | 4 | 2020 | 172 | 1.270 |
Why?
|
| Natural Killer T-Cells | 3 | 2018 | 125 | 1.260 |
Why?
|
| Toll-Like Receptors | 6 | 2015 | 177 | 1.220 |
Why?
|
| B-Lymphocytes | 9 | 2021 | 1353 | 1.210 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2014 | 2560 | 1.210 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 5 | 2020 | 271 | 1.200 |
Why?
|
| Interleukin-15 | 2 | 2019 | 188 | 1.190 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 5 | 2018 | 94 | 1.190 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 6 | 2016 | 96 | 1.180 |
Why?
|
| NF-kappa B p50 Subunit | 12 | 2011 | 55 | 1.130 |
Why?
|
| Enzyme Activation | 21 | 2014 | 1800 | 0.970 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2019 | 1462 | 0.970 |
Why?
|
| Jurkat Cells | 20 | 2015 | 315 | 0.960 |
Why?
|
| Cell Line | 36 | 2021 | 5132 | 0.950 |
Why?
|
| Intestinal Mucosa | 3 | 2020 | 1104 | 0.930 |
Why?
|
| TNF Receptor-Associated Factor 2 | 6 | 2020 | 40 | 0.920 |
Why?
|
| Macrophages | 10 | 2020 | 1372 | 0.910 |
Why?
|
| Protein Binding | 23 | 2020 | 3483 | 0.910 |
Why?
|
| Deubiquitinating Enzyme CYLD | 12 | 2011 | 23 | 0.900 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2010 | 1878 | 0.900 |
Why?
|
| Transcriptional Activation | 11 | 2014 | 1096 | 0.900 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2005 | 1589 | 0.870 |
Why?
|
| B-Cell Activating Factor | 2 | 2021 | 25 | 0.870 |
Why?
|
| DNA-Binding Proteins | 20 | 2010 | 4911 | 0.870 |
Why?
|
| Melanoma, Experimental | 3 | 2021 | 377 | 0.870 |
Why?
|
| Phosphorylation | 26 | 2020 | 4887 | 0.870 |
Why?
|
| Immunoblotting | 15 | 2015 | 900 | 0.860 |
Why?
|
| Immune Tolerance | 4 | 2019 | 408 | 0.850 |
Why?
|
| Ubiquitin-Specific Proteases | 4 | 2018 | 71 | 0.820 |
Why?
|
| Apoptosis | 14 | 2015 | 7759 | 0.810 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 2020 | 1168 | 0.800 |
Why?
|
| Inflammation Mediators | 3 | 2022 | 430 | 0.800 |
Why?
|
| NFATC Transcription Factors | 6 | 2022 | 102 | 0.800 |
Why?
|
| Immunity, Mucosal | 2 | 2020 | 113 | 0.800 |
Why?
|
| Endopeptidases | 3 | 2016 | 226 | 0.800 |
Why?
|
| Interleukin-17 | 4 | 2020 | 264 | 0.800 |
Why?
|
| CD28 Antigens | 7 | 2014 | 204 | 0.790 |
Why?
|
| Myeloid Cells | 2 | 2022 | 276 | 0.750 |
Why?
|
| Leukemia, B-Cell | 1 | 2021 | 114 | 0.750 |
Why?
|
| Retinoids | 4 | 2002 | 171 | 0.740 |
Why?
|
| Th1 Cells | 4 | 2015 | 259 | 0.740 |
Why?
|
| Protein Multimerization | 1 | 2021 | 243 | 0.730 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 117 | 0.730 |
Why?
|
| HEK293 Cells | 10 | 2020 | 1513 | 0.720 |
Why?
|
| Arthritis, Psoriatic | 1 | 2020 | 28 | 0.700 |
Why?
|
| Moths | 8 | 1995 | 36 | 0.690 |
Why?
|
| Inflammasomes | 1 | 2021 | 167 | 0.690 |
Why?
|
| Homeostasis | 5 | 2018 | 947 | 0.680 |
Why?
|
| Colitis | 3 | 2022 | 338 | 0.680 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 4245 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2006 | 696 | 0.650 |
Why?
|
| Epithelial Cells | 5 | 2020 | 1848 | 0.650 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 225 | 0.650 |
Why?
|
| Intestinal Neoplasms | 1 | 2020 | 197 | 0.630 |
Why?
|
| Interleukin-2 | 6 | 2014 | 851 | 0.630 |
Why?
|
| Lipopolysaccharides | 15 | 2014 | 589 | 0.610 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2012 | 592 | 0.600 |
Why?
|
| Energy Metabolism | 2 | 2021 | 1008 | 0.600 |
Why?
|
| Multiprotein Complexes | 3 | 2015 | 387 | 0.590 |
Why?
|
| Autoimmune Diseases | 3 | 2021 | 418 | 0.590 |
Why?
|
| Flow Cytometry | 11 | 2018 | 3074 | 0.580 |
Why?
|
| Transfection | 24 | 2005 | 2989 | 0.580 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2021 | 1792 | 0.580 |
Why?
|
| Autophagy | 4 | 2020 | 931 | 0.560 |
Why?
|
| Carcinogenesis | 2 | 2021 | 1049 | 0.560 |
Why?
|
| Lymphatic Vessels | 1 | 2018 | 146 | 0.560 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2019 | 670 | 0.540 |
Why?
|
| Humans | 108 | 2022 | 270843 | 0.540 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 2 | 2013 | 77 | 0.540 |
Why?
|
| Thymus Gland | 2 | 2015 | 298 | 0.540 |
Why?
|
| Cytokines | 6 | 2022 | 2871 | 0.540 |
Why?
|
| Molecular Sequence Data | 28 | 2016 | 6127 | 0.540 |
Why?
|
| Proteins | 6 | 2011 | 1989 | 0.530 |
Why?
|
| Membrane Glycoproteins | 5 | 2012 | 1111 | 0.530 |
Why?
|
| Deubiquitinating Enzymes | 3 | 2021 | 37 | 0.520 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1007 | 0.520 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2005 | 203 | 0.510 |
Why?
|
| Cells, Cultured | 9 | 2020 | 5670 | 0.510 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2020 | 2397 | 0.510 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 2 | 2005 | 41 | 0.500 |
Why?
|
| Golgi Apparatus | 2 | 2015 | 145 | 0.500 |
Why?
|
| Protein Processing, Post-Translational | 7 | 2008 | 802 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 4 | 2013 | 886 | 0.500 |
Why?
|
| Membrane Proteins | 4 | 2022 | 2917 | 0.490 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2012 | 472 | 0.480 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2014 | 11 | 0.480 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2012 | 67 | 0.480 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2014 | 416 | 0.470 |
Why?
|
| Amino Acid Sequence | 18 | 2016 | 4281 | 0.460 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 931 | 0.460 |
Why?
|
| Germinal Center | 2 | 2013 | 168 | 0.450 |
Why?
|
| Transcription Factors | 11 | 2022 | 5362 | 0.440 |
Why?
|
| Protein Precursors | 4 | 2005 | 247 | 0.440 |
Why?
|
| Adoptive Transfer | 5 | 2015 | 445 | 0.440 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 91 | 0.440 |
Why?
|
| Multienzyme Complexes | 5 | 2004 | 222 | 0.440 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2012 | 16 | 0.430 |
Why?
|
| Cell Survival | 9 | 2018 | 3062 | 0.430 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2012 | 51 | 0.420 |
Why?
|
| Hematopoiesis | 3 | 2018 | 573 | 0.420 |
Why?
|
| Proteasome Endopeptidase Complex | 7 | 2006 | 593 | 0.420 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 1429 | 0.420 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 365 | 0.420 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 530 | 0.410 |
Why?
|
| Glutamine | 1 | 2014 | 303 | 0.410 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2012 | 7 | 0.410 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2012 | 172 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 13 | 2014 | 3109 | 0.410 |
Why?
|
| Mitochondria | 2 | 2018 | 1307 | 0.410 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 84 | 0.410 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 3294 | 0.400 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2011 | 24 | 0.400 |
Why?
|
| Immunoglobulin A | 1 | 2012 | 249 | 0.400 |
Why?
|
| Vesicular Stomatitis | 1 | 2011 | 14 | 0.400 |
Why?
|
| Cell Line, Tumor | 15 | 2021 | 14855 | 0.400 |
Why?
|
| Endothelial Cells | 1 | 2018 | 1077 | 0.400 |
Why?
|
| TNF Receptor-Associated Factor 6 | 4 | 2014 | 38 | 0.390 |
Why?
|
| Neoplasms | 8 | 2022 | 15710 | 0.390 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2022 | 96 | 0.390 |
Why?
|
| Proteolysis | 4 | 2015 | 376 | 0.390 |
Why?
|
| Mutagenesis | 7 | 2003 | 482 | 0.380 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 1560 | 0.370 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 1997 | 217 | 0.370 |
Why?
|
| Base Sequence | 21 | 2011 | 4932 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 518 | 0.360 |
Why?
|
| Feedback, Physiological | 2 | 2010 | 196 | 0.360 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 215 | 0.360 |
Why?
|
| Lymphopoiesis | 1 | 2010 | 17 | 0.360 |
Why?
|
| NF-KappaB Inhibitor alpha | 11 | 2010 | 138 | 0.360 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2011 | 134 | 0.360 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 297 | 0.360 |
Why?
|
| STAT3 Transcription Factor | 6 | 2018 | 1139 | 0.350 |
Why?
|
| Interferon Type I | 3 | 2019 | 261 | 0.350 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2010 | 183 | 0.350 |
Why?
|
| Protein Structure, Tertiary | 8 | 2005 | 1506 | 0.340 |
Why?
|
| Plasmids | 7 | 2006 | 844 | 0.340 |
Why?
|
| Lysine | 3 | 2016 | 428 | 0.340 |
Why?
|
| Transcription Factor RelA | 11 | 2014 | 185 | 0.340 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 96 | 0.330 |
Why?
|
| Lithium Chloride | 1 | 2008 | 28 | 0.330 |
Why?
|
| Virus Diseases | 2 | 2014 | 400 | 0.330 |
Why?
|
| Carrier Proteins | 3 | 2015 | 2055 | 0.330 |
Why?
|
| Binding Sites | 11 | 2005 | 2210 | 0.320 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2005 | 307 | 0.320 |
Why?
|
| Amino Acid Motifs | 4 | 2005 | 412 | 0.320 |
Why?
|
| Cell Nucleus | 12 | 2006 | 1642 | 0.320 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2008 | 47 | 0.310 |
Why?
|
| Tumor Cells, Cultured | 15 | 2003 | 5511 | 0.310 |
Why?
|
| Phosphoserine | 2 | 2005 | 109 | 0.310 |
Why?
|
| Oxazoles | 3 | 1997 | 63 | 0.310 |
Why?
|
| Immunotherapy | 2 | 2022 | 3481 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-rel | 5 | 2014 | 26 | 0.310 |
Why?
|
| Cell Transformation, Viral | 3 | 2012 | 136 | 0.300 |
Why?
|
| Glycolysis | 2 | 2021 | 530 | 0.300 |
Why?
|
| Bone Resorption | 1 | 2008 | 137 | 0.300 |
Why?
|
| Central Nervous System | 3 | 2015 | 449 | 0.290 |
Why?
|
| Lymph Nodes | 2 | 2018 | 3033 | 0.290 |
Why?
|
| Osteoclasts | 1 | 2008 | 160 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2018 | 1293 | 0.290 |
Why?
|
| Precipitin Tests | 5 | 2006 | 336 | 0.290 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 2 | 2020 | 38 | 0.280 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2014 | 209 | 0.280 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2008 | 553 | 0.280 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 1005 | 0.280 |
Why?
|
| Mice, 129 Strain | 2 | 2020 | 165 | 0.270 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2020 | 16 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2011 | 3666 | 0.270 |
Why?
|
| Immunoprecipitation | 4 | 2015 | 590 | 0.270 |
Why?
|
| Immunomodulation | 2 | 2022 | 255 | 0.270 |
Why?
|
| Antidepressive Agents | 1 | 2008 | 342 | 0.260 |
Why?
|
| Repressor Proteins | 2 | 2012 | 1699 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 383 | 0.260 |
Why?
|
| Retroviridae | 5 | 2005 | 323 | 0.260 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 7429 | 0.260 |
Why?
|
| Spermatogenesis | 1 | 2007 | 322 | 0.260 |
Why?
|
| Germ Cells | 1 | 2007 | 339 | 0.260 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 1233 | 0.250 |
Why?
|
| Ubiquitins | 3 | 2020 | 88 | 0.250 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2005 | 23 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 1506 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2018 | 9067 | 0.240 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2016 | 512 | 0.240 |
Why?
|
| Fenretinide | 2 | 2002 | 98 | 0.240 |
Why?
|
| Blood Cells | 2 | 2018 | 123 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2006 | 1597 | 0.230 |
Why?
|
| Aminacrine | 1 | 2003 | 1 | 0.230 |
Why?
|
| Gene Deletion | 3 | 2015 | 1476 | 0.230 |
Why?
|
| Adaptive Immunity | 2 | 2017 | 157 | 0.230 |
Why?
|
| Genes, Immunoglobulin | 2 | 1995 | 87 | 0.220 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2003 | 73 | 0.220 |
Why?
|
| Interferon-gamma | 2 | 2018 | 1163 | 0.210 |
Why?
|
| Peptide Synthases | 1 | 2002 | 8 | 0.210 |
Why?
|
| Transducin | 1 | 2002 | 40 | 0.210 |
Why?
|
| Mutagens | 1 | 2003 | 186 | 0.210 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2022 | 57 | 0.200 |
Why?
|
| Biological Assay | 1 | 2003 | 175 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2012 | 40 | 0.200 |
Why?
|
| HIV-1 | 5 | 2009 | 679 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2018 | 1515 | 0.200 |
Why?
|
| Interferon-beta | 3 | 2014 | 107 | 0.200 |
Why?
|
| Gene Expression | 8 | 2016 | 3594 | 0.200 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2016 | 102 | 0.200 |
Why?
|
| Transcription, Genetic | 11 | 2014 | 3148 | 0.200 |
Why?
|
| Cell Separation | 3 | 2015 | 599 | 0.200 |
Why?
|
| Fibroblasts | 4 | 2014 | 1693 | 0.200 |
Why?
|
| Tretinoin | 2 | 2002 | 637 | 0.200 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2013 | 200 | 0.200 |
Why?
|
| Hypertrophy | 1 | 2022 | 164 | 0.200 |
Why?
|
| Up-Regulation | 3 | 2012 | 2480 | 0.200 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2014 | 473 | 0.190 |
Why?
|
| Lung | 3 | 2019 | 3245 | 0.190 |
Why?
|
| DNA, Complementary | 5 | 2005 | 882 | 0.190 |
Why?
|
| RANK Ligand | 2 | 2014 | 120 | 0.190 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2021 | 28 | 0.190 |
Why?
|
| Cell Line, Transformed | 4 | 2007 | 397 | 0.190 |
Why?
|
| Caspases | 3 | 2014 | 685 | 0.190 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 2 | 2011 | 21 | 0.190 |
Why?
|
| Hexokinase | 1 | 2021 | 41 | 0.190 |
Why?
|
| Enzyme Stability | 1 | 2021 | 108 | 0.190 |
Why?
|
| Sequence Deletion | 3 | 2016 | 880 | 0.190 |
Why?
|
| Metallothionein | 1 | 2020 | 34 | 0.190 |
Why?
|
| Leukemia, T-Cell | 4 | 2012 | 88 | 0.190 |
Why?
|
| NADP | 1 | 2021 | 95 | 0.180 |
Why?
|
| Substrate Specificity | 3 | 2009 | 559 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2006 | 657 | 0.180 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 307 | 0.180 |
Why?
|
| Genes, APC | 1 | 2020 | 73 | 0.180 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2016 | 283 | 0.180 |
Why?
|
| Organ Specificity | 1 | 2022 | 704 | 0.180 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2020 | 53 | 0.180 |
Why?
|
| Phenotype | 3 | 2021 | 6404 | 0.180 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 250 | 0.180 |
Why?
|
| CD40 Antigens | 3 | 2005 | 111 | 0.180 |
Why?
|
| Serine | 2 | 2004 | 389 | 0.170 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2019 | 20 | 0.170 |
Why?
|
| A549 Cells | 1 | 2019 | 132 | 0.170 |
Why?
|
| Self Tolerance | 1 | 2019 | 18 | 0.170 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 159 | 0.170 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2019 | 105 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 546 | 0.170 |
Why?
|
| Anticarcinogenic Agents | 1 | 2001 | 366 | 0.160 |
Why?
|
| HIV Long Terminal Repeat | 2 | 1996 | 26 | 0.160 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2018 | 12 | 0.160 |
Why?
|
| Cancer Vaccines | 2 | 2022 | 727 | 0.160 |
Why?
|
| Leupeptins | 3 | 2014 | 69 | 0.160 |
Why?
|
| Coculture Techniques | 1 | 2020 | 632 | 0.160 |
Why?
|
| Zinc Fingers | 2 | 2018 | 214 | 0.160 |
Why?
|
| B-Cell Activation Factor Receptor | 2 | 2011 | 26 | 0.160 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 688 | 0.160 |
Why?
|
| Milk Proteins | 1 | 1999 | 122 | 0.160 |
Why?
|
| CD3 Complex | 3 | 2010 | 316 | 0.160 |
Why?
|
| Oligonucleotide Probes | 3 | 2013 | 132 | 0.160 |
Why?
|
| Karyopherins | 1 | 1999 | 135 | 0.160 |
Why?
|
| Genes, Insect | 3 | 1995 | 130 | 0.160 |
Why?
|
| Chemokine CXCL13 | 1 | 2018 | 21 | 0.160 |
Why?
|
| Insect Proteins | 4 | 1995 | 96 | 0.150 |
Why?
|
| Mitogens | 3 | 2005 | 76 | 0.150 |
Why?
|
| Retroviridae Proteins, Oncogenic | 2 | 1997 | 39 | 0.150 |
Why?
|
| Protein Stability | 1 | 2019 | 374 | 0.150 |
Why?
|
| Adenocarcinoma in Situ | 1 | 2018 | 31 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 2 | 2009 | 128 | 0.150 |
Why?
|
| Biological Transport | 3 | 2014 | 605 | 0.150 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2008 | 100 | 0.150 |
Why?
|
| Silicon Dioxide | 5 | 1997 | 50 | 0.150 |
Why?
|
| Leucine | 2 | 2014 | 362 | 0.140 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 495 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 489 | 0.140 |
Why?
|
| RNA Interference | 4 | 2018 | 1411 | 0.140 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2016 | 18 | 0.140 |
Why?
|
| Receptors, Cell Surface | 2 | 2013 | 879 | 0.140 |
Why?
|
| Mutation | 10 | 2014 | 15642 | 0.140 |
Why?
|
| Cytoplasm | 5 | 2003 | 653 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 311 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2022 | 775 | 0.140 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 223 | 0.140 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 435 | 0.130 |
Why?
|
| Insulin Resistance | 1 | 2022 | 744 | 0.130 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 1149 | 0.130 |
Why?
|
| Gene Products, tat | 1 | 1996 | 60 | 0.130 |
Why?
|
| HeLa Cells | 4 | 2006 | 1653 | 0.130 |
Why?
|
| Dithiothreitol | 1 | 1995 | 21 | 0.130 |
Why?
|
| DNA | 11 | 1998 | 2745 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 37 | 0.130 |
Why?
|
| Glucose | 1 | 2022 | 1267 | 0.130 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 69 | 0.130 |
Why?
|
| Proto-Oncogenes | 2 | 1998 | 202 | 0.130 |
Why?
|
| B7-H1 Antigen | 2 | 2020 | 1057 | 0.130 |
Why?
|
| Enzyme Inhibitors | 4 | 1997 | 1937 | 0.130 |
Why?
|
| Acetylcysteine | 2 | 1995 | 147 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 599 | 0.130 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2015 | 86 | 0.120 |
Why?
|
| Cell Division | 5 | 2003 | 2556 | 0.120 |
Why?
|
| Orthomyxoviridae | 1 | 2015 | 96 | 0.120 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 184 | 0.120 |
Why?
|
| Hematopoietic System | 1 | 2014 | 25 | 0.120 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2014 | 25 | 0.120 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2014 | 30 | 0.120 |
Why?
|
| Trans-Activators | 2 | 1999 | 1624 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2002 | 11817 | 0.120 |
Why?
|
| Immunity, Cellular | 1 | 2016 | 431 | 0.120 |
Why?
|
| Blotting, Northern | 3 | 2000 | 698 | 0.120 |
Why?
|
| Bone Marrow Cells | 4 | 2016 | 931 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2006 | 164 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 39 | 0.120 |
Why?
|
| Listeriosis | 1 | 2014 | 36 | 0.120 |
Why?
|
| Genes, Reporter | 5 | 2016 | 811 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2013 | 22 | 0.120 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 53 | 0.120 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 230 | 0.120 |
Why?
|
| Oncogenes | 2 | 1996 | 677 | 0.120 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 112 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2019 | 2084 | 0.110 |
Why?
|
| Guanylate Cyclase | 1 | 2013 | 76 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 485 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2014 | 353 | 0.110 |
Why?
|
| Oxidants | 2 | 2011 | 50 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 1514 | 0.110 |
Why?
|
| Thymocytes | 1 | 2012 | 19 | 0.110 |
Why?
|
| Human T-lymphotropic virus 2 | 1 | 2012 | 3 | 0.110 |
Why?
|
| Immune System | 2 | 2011 | 283 | 0.110 |
Why?
|
| Immunization | 2 | 2011 | 402 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2012 | 19 | 0.110 |
Why?
|
| Marine Toxins | 3 | 1997 | 13 | 0.100 |
Why?
|
| Cell Movement | 2 | 2015 | 2499 | 0.100 |
Why?
|
| Insect Hormones | 2 | 1993 | 15 | 0.100 |
Why?
|
| Macrophages, Alveolar | 3 | 1997 | 71 | 0.100 |
Why?
|
| Genes, Dominant | 2 | 2004 | 344 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 4 | 2000 | 227 | 0.100 |
Why?
|
| Female | 15 | 2021 | 147292 | 0.100 |
Why?
|
| Biomarkers | 2 | 2022 | 5176 | 0.100 |
Why?
|
| Molecular Weight | 4 | 2001 | 633 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2012 | 61 | 0.100 |
Why?
|
| Male | 10 | 2021 | 127630 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2014 | 253 | 0.100 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2981 | 0.100 |
Why?
|
| Protein Subunits | 2 | 2005 | 283 | 0.100 |
Why?
|
| Insecta | 1 | 1992 | 75 | 0.100 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2013 | 224 | 0.100 |
Why?
|
| RNA, Messenger | 7 | 2001 | 6224 | 0.100 |
Why?
|
| Histones | 3 | 2014 | 1493 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 2 | 2015 | 770 | 0.100 |
Why?
|
| Microglia | 1 | 2013 | 177 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2005 | 307 | 0.100 |
Why?
|
| Macrophage Activation | 2 | 2006 | 147 | 0.100 |
Why?
|
| Luciferases | 3 | 2001 | 454 | 0.100 |
Why?
|
| Muramidase | 1 | 1991 | 108 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 257 | 0.100 |
Why?
|
| Leukocyte Common Antigens | 1 | 2011 | 190 | 0.090 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 635 | 0.090 |
Why?
|
| Isoenzymes | 3 | 2006 | 633 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 1006 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2009 | 3596 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1891 | 0.090 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2001 | 210 | 0.090 |
Why?
|
| Herpesvirus 8, Human | 1 | 2011 | 105 | 0.090 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2010 | 46 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2012 | 376 | 0.090 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2009 | 7 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2003 | 195 | 0.090 |
Why?
|
| Recombinant Proteins | 5 | 2001 | 2943 | 0.090 |
Why?
|
| Embryo Loss | 1 | 2009 | 42 | 0.090 |
Why?
|
| Endonucleases | 1 | 2010 | 179 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 164 | 0.090 |
Why?
|
| Bone and Bones | 2 | 2016 | 604 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1470 | 0.090 |
Why?
|
| Interleukin-7 | 1 | 2010 | 96 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 1061 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2018 | 1288 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 516 | 0.090 |
Why?
|
| Interferons | 1 | 2011 | 300 | 0.080 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2009 | 40 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2012 | 491 | 0.080 |
Why?
|
| Multigene Family | 1 | 1990 | 429 | 0.080 |
Why?
|
| Interleukin-1 | 2 | 2004 | 480 | 0.080 |
Why?
|
| COS Cells | 3 | 2009 | 388 | 0.080 |
Why?
|
| Immunophenotyping | 2 | 2016 | 1701 | 0.080 |
Why?
|
| Sjogren's Syndrome | 1 | 2010 | 108 | 0.080 |
Why?
|
| Time Factors | 4 | 2004 | 13266 | 0.080 |
Why?
|
| Fas Ligand Protein | 2 | 2000 | 153 | 0.080 |
Why?
|
| Atrophy | 1 | 2009 | 270 | 0.080 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2009 | 66 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2014 | 1057 | 0.080 |
Why?
|
| Melanoma | 2 | 2016 | 5445 | 0.080 |
Why?
|
| Transcription Factor TFIIH | 1 | 2008 | 20 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 166 | 0.080 |
Why?
|
| Intestines | 1 | 2013 | 693 | 0.080 |
Why?
|
| Bacteria | 1 | 2013 | 626 | 0.080 |
Why?
|
| Transcription Factor RelB | 3 | 1996 | 18 | 0.080 |
Why?
|
| Integrases | 1 | 2009 | 267 | 0.080 |
Why?
|
| Catalysis | 2 | 1998 | 251 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 161 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2001 | 627 | 0.080 |
Why?
|
| Models, Biological | 2 | 2010 | 3255 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2016 | 2381 | 0.080 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 1295 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 2223 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2009 | 399 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 1997 | 93 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 620 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2010 | 385 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2000 | 318 | 0.070 |
Why?
|
| Cell Compartmentation | 2 | 1999 | 79 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 3623 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 624 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2001 | 5466 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1801 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 954 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2012 | 2117 | 0.070 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2006 | 29 | 0.070 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 111 | 0.070 |
Why?
|
| Collagen Type XI | 1 | 2005 | 7 | 0.070 |
Why?
|
| Autoradiography | 1 | 2006 | 133 | 0.070 |
Why?
|
| Antigens, Differentiation | 1 | 2007 | 247 | 0.070 |
Why?
|
| TRPM Cation Channels | 1 | 2005 | 9 | 0.070 |
Why?
|
| Osteoporosis | 1 | 2008 | 233 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 245 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 1142 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2001 | 4076 | 0.070 |
Why?
|
| beta Catenin | 1 | 2009 | 697 | 0.070 |
Why?
|
| DNA Probes | 3 | 2011 | 219 | 0.060 |
Why?
|
| Hyperplasia | 1 | 2007 | 567 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2009 | 763 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 639 | 0.060 |
Why?
|
| Organ Size | 1 | 2007 | 732 | 0.060 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2004 | 16 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2005 | 90 | 0.060 |
Why?
|
| DNA Primers | 2 | 2010 | 1422 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 367 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 214 | 0.060 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 143 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2005 | 122 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 182 | 0.060 |
Why?
|
| Immunoglobulins | 3 | 1995 | 268 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 1997 | 239 | 0.060 |
Why?
|
| Ankyrin Repeat | 1 | 2003 | 15 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2003 | 46 | 0.060 |
Why?
|
| Epitopes | 2 | 2016 | 696 | 0.060 |
Why?
|
| Kinetics | 3 | 1997 | 2098 | 0.060 |
Why?
|
| Spleen | 2 | 2003 | 692 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2009 | 1859 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2009 | 1294 | 0.060 |
Why?
|
| Cell Death | 1 | 2005 | 675 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2005 | 850 | 0.050 |
Why?
|
| DNA Fragmentation | 2 | 2000 | 199 | 0.050 |
Why?
|
| Cycloheximide | 2 | 1993 | 99 | 0.050 |
Why?
|
| Drug Synergism | 2 | 1997 | 1337 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 1226 | 0.050 |
Why?
|
| Stem Cells | 1 | 2009 | 1244 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2022 | 56 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 2 | 2018 | 570 | 0.050 |
Why?
|
| Gene Library | 1 | 2003 | 300 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2012 | 2736 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2004 | 257 | 0.050 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2002 | 44 | 0.050 |
Why?
|
| Stem Cell Factor | 1 | 2002 | 89 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2002 | 14506 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 12451 | 0.050 |
Why?
|
| Carcinoma, Large Cell | 1 | 2002 | 95 | 0.050 |
Why?
|
| Vitamin E | 1 | 2022 | 135 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2002 | 199 | 0.050 |
Why?
|
| Erythroid Precursor Cells | 2 | 1998 | 66 | 0.050 |
Why?
|
| Cross-Linking Reagents | 2 | 2012 | 154 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 915 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2001 | 96 | 0.050 |
Why?
|
| Caspase 7 | 1 | 2000 | 33 | 0.050 |
Why?
|
| Protein Transport | 1 | 2003 | 745 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 70 | 0.050 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2002 | 139 | 0.050 |
Why?
|
| Leucine Zippers | 1 | 2000 | 39 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2000 | 99 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 303 | 0.050 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2000 | 62 | 0.050 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2000 | 28 | 0.050 |
Why?
|
| Annexin A5 | 1 | 2000 | 75 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2000 | 148 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1508 | 0.050 |
Why?
|
| Genotype | 2 | 2016 | 4168 | 0.040 |
Why?
|
| Viral Envelope Proteins | 1 | 2001 | 214 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5235 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2000 | 189 | 0.040 |
Why?
|
| Oncogene Proteins v-rel | 2 | 1997 | 7 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 73 | 0.040 |
Why?
|
| Alkaloids | 2 | 1997 | 80 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2001 | 368 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1994 | 118 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 130 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2000 | 480 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 703 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1999 | 96 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 1997 | 225 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2000 | 470 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2004 | 1712 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 1999 | 112 | 0.040 |
Why?
|
| Octamer Transcription Factors | 1 | 2018 | 18 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 1991 | 3096 | 0.040 |
Why?
|
| Erythropoiesis | 1 | 1998 | 77 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 99 | 0.040 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 91 | 0.040 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2018 | 103 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 1999 | 224 | 0.040 |
Why?
|
| Phytohemagglutinins | 1 | 1997 | 70 | 0.040 |
Why?
|
| Benzylisoquinolines | 1 | 1997 | 2 | 0.040 |
Why?
|
| RNA | 1 | 2002 | 1030 | 0.040 |
Why?
|
| Erythropoietin | 1 | 1998 | 211 | 0.040 |
Why?
|
| Pancreatitis, Chronic | 1 | 2018 | 124 | 0.040 |
Why?
|
| Calpain | 1 | 1997 | 70 | 0.040 |
Why?
|
| Calcium | 2 | 2005 | 1558 | 0.040 |
Why?
|
| Activating Transcription Factors | 1 | 1996 | 7 | 0.040 |
Why?
|
| Haplorhini | 1 | 1996 | 136 | 0.030 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 259 | 0.030 |
Why?
|
| Trypsin | 1 | 1996 | 140 | 0.030 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 7 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2016 | 18 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 1996 | 67 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2000 | 1123 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 73 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 1996 | 49 | 0.030 |
Why?
|
| Methylcholanthrene | 1 | 2015 | 31 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 7704 | 0.030 |
Why?
|
| Ethers, Cyclic | 1 | 1995 | 16 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1995 | 28 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1997 | 284 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2018 | 1091 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 571 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2015 | 66 | 0.030 |
Why?
|
| fas Receptor | 1 | 1996 | 193 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 4452 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1996 | 192 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1992 | 298 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 2015 | 135 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 132 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 1995 | 88 | 0.030 |
Why?
|
| Hemolymph | 2 | 1993 | 5 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1996 | 297 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 705 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1997 | 965 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2014 | 37 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2015 | 234 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 208 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 200 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2013 | 258 | 0.030 |
Why?
|
| Lymphopenia | 1 | 2016 | 206 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 729 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1993 | 64 | 0.030 |
Why?
|
| Ankyrins | 1 | 1994 | 107 | 0.030 |
Why?
|
| HTLV-II Infections | 1 | 2012 | 1 | 0.030 |
Why?
|
| Pupa | 1 | 1992 | 21 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 362 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1996 | 726 | 0.030 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2012 | 11 | 0.030 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2012 | 13 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 1182 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2014 | 147 | 0.030 |
Why?
|
| Immune Sera | 1 | 1992 | 147 | 0.030 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1992 | 73 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 4343 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1992 | 301 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1992 | 61 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1994 | 674 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1993 | 188 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 158 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 165 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1995 | 659 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 463 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 1079 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 600 | 0.020 |
Why?
|
| Ligands | 1 | 2014 | 1009 | 0.020 |
Why?
|
| Interleukins | 1 | 2013 | 340 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2013 | 182 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 266 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2011 | 122 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1992 | 232 | 0.020 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2012 | 284 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 404 | 0.020 |
Why?
|
| Transcription Factor HES-1 | 1 | 2010 | 49 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2018 | 2319 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 355 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2012 | 317 | 0.020 |
Why?
|
| OX40 Ligand | 1 | 2010 | 28 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2011 | 266 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 342 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 178 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 40 | 0.020 |
Why?
|
| Peptides | 1 | 2016 | 1504 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2016 | 1069 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2010 | 82 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 5242 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 237 | 0.020 |
Why?
|
| Janus Kinase 1 | 1 | 2010 | 125 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 1430 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 367 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2013 | 905 | 0.020 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2009 | 141 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2010 | 262 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6269 | 0.020 |
Why?
|
| Drosophila | 1 | 1993 | 856 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 1638 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1578 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 1410 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1497 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2009 | 768 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 6891 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2341 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1101 | 0.020 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 2 | 1995 | 5 | 0.020 |
Why?
|
| omega-N-Methylarginine | 2 | 1995 | 35 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1708 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 2403 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 738 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 2200 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 2 | 1995 | 322 | 0.020 |
Why?
|
| Tyrosine | 2 | 1995 | 508 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1995 | 261 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 7908 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2005 | 597 | 0.010 |
Why?
|
| Arginine | 2 | 1995 | 518 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2001 | 31 | 0.010 |
Why?
|
| Immunoglobulin D | 1 | 2001 | 16 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 7303 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 1158 | 0.010 |
Why?
|
| Rats | 2 | 1997 | 6208 | 0.010 |
Why?
|
| Isocoumarins | 1 | 1997 | 6 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1998 | 119 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 22249 | 0.010 |
Why?
|
| Coumarins | 1 | 1997 | 34 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1997 | 62 | 0.010 |
Why?
|
| Chloroquine | 1 | 1997 | 56 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 16053 | 0.010 |
Why?
|
| Lamins | 1 | 1996 | 9 | 0.010 |
Why?
|
| Lamin Type B | 1 | 1996 | 9 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1997 | 59 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 856 | 0.010 |
Why?
|
| Genes, myc | 1 | 1998 | 360 | 0.010 |
Why?
|
| Sp1 Transcription Factor | 1 | 1997 | 190 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1997 | 214 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 978 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1995 | 114 | 0.010 |
Why?
|
| Indomethacin | 1 | 1995 | 94 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1995 | 251 | 0.010 |
Why?
|
| Staurosporine | 1 | 1995 | 144 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 1997 | 540 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1995 | 212 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1995 | 397 | 0.010 |
Why?
|
| Aspirin | 1 | 1997 | 473 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1993 | 220 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1993 | 339 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1993 | 279 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1993 | 908 | 0.010 |
Why?
|
| Point Mutation | 1 | 1993 | 781 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1993 | 1271 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 5030 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 2317 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1993 | 1223 | 0.000 |
Why?
|